drugset / Trial / NCT00384605
An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)
RandomizedParallel-groupDouble-blindTreatment
Summary
A 1 year worldwide study in obese and overweight patients to assess the safety and effect on body weight of an investigational weight loss drug.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-01
- Completion
- 2008-12
Outcome
Outcome not reported
Stopped: “The overall profile does not support development for obesity”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | taranabant | Unknown | 0.5 mg | — |
| Subject | taranabant | Unknown | 1 mg | — |
| Subject | taranabant | Unknown | 2 mg | — |